Physiomics Share Discussion Threads

[the stigologist] 03/5/2018 11:03

There has been no placing for almost two years

[officerdigby] 03/5/2018 10:49

Anyone got number of issued shares vs time for this Co? Stig surely you've got this data.. right

[smcl] 03/5/2018 10:26

Still be a loud mouthed dipstick though albeit a very wealthy one! Ha ha

[smcl] 03/5/2018 10:25

No total rubbish a Trillion bagger. STUG/STUCK will be a Trillionaire!!!

[davevt] 03/5/2018 10:07

Rubbish, it will be a MILLION bagger!

[the stigologist] 02/5/2018 23:39

Very real possibility of not just a Ten Bagger here, not even just a hundred bagger but a THOUSAND BAGGER for some

Imagine that. Turn 1k into £1m

At 1p this Company had a Market Cap of £0.5m
At 100p it'll be c.£60m
At 1000p it'll be c.£600m

[the stigologist] 02/5/2018 23:37

Not often you come across a stock which can TEN BAG and still be cheap !

[marktyson] 02/5/2018 22:27

The bowl formation of the chart looks to be in a very nice place right now.

[the stigologist] 02/5/2018 21:36

#PYC Physiomics

the short, medium and long term trends look amazing for PYC
it has shown capability to super-spike to 100p+ in the past

[myamay16] 02/5/2018 21:28

Look what company had 1st Quarter results yesterday, digest and research relevant avenues, notice time of majority buys today!!!

[hms_trader] 02/5/2018 20:42

Great posting by Stig. Haters will hate and ultimately lose, this is building beautifully

[smcl] 02/5/2018 19:54

More repetitive posts from STUG/STUCK

[the stigologist] 02/5/2018 19:30

hmm...

Now why would the Cancer Research UK be looking for a Mathematical Biologist...with SPECIFIC skills in 'modelling and simulation for pre-clinical and clinical trials'



Mathematical Biologist
Reference Number: MI/18/28
Starting Salary: in the range of £24,776 - £41,536 per annum (depending upon experience)
Closing Date: 03 June 2018
Duration of Post: Fixed term until 31st March 2022

About the role:
The overall goal of the Clinical and Experimental Pharmacology Group (CEP) in the CRUK Manchester Institute, led by Professor Caroline Dive CBE, is to develop, validate, and implement biomarkers that facilitate the optimisation of cancer patient treatment – personalised medicine. The overall goal of our Drug Discovery Unit (DDU), led by Professor Caroline Springer is to discover and develop new treatments for cancer patients.

The DDU and CEP have strong track records in bringing new therapies to the cancer clinic and the implementation of biomarkers (notably liquid biopsies) for patient management. Mathematical biology is critical to research missions to deliver personalised medicine to cancer patients. Specifically, we require skills in pharmacokinetic and pharmacodynamic (PK/PD) modelling and simulation in preclinical studies and in early clinical trials, along with input to biomarker biostatistics studies.

An exciting opportunity now presents for a Mathematical Biologist to join CEP and the DDU, positioned within the newly established Manchester Centre for Cancer Biomarker Sciences (MCCBS) Bioinformatics and Biostatistics team (BBS) led by Dr Crispin Miller. You will work alongside a multidisciplinary team of clinicians, biologists, chemists and computational scientists to conduct PK/PD modelling and biostatistics analysis using existing methods and, where relevant, to develop novel methods. The post will encompass a range of developmental therapeutic studies in preclinical models and biomarker analyses on clinical trials. The post will be associated with the Centre of Applied Pharmacokinetic Research (CAPKR) led by Prof Leon Aarons within the Division of Pharmacy and Optometry at The University of Manchester.

[the stigologist] 02/5/2018 17:55

No news this week yet the stock is acting like it wants to blast off

Chart seems to be setting itself up for a 'moonshoot'

Nobody can be certain about these things but as somebody who has called it right here consistently I can feel a big transformational RNS is on the way

There are several items of news due/overdue

We know the Industry 'mood music' is all very very positive at the moment

I would not want to be short of this...

[coldspring] 02/5/2018 17:45

Hey Dave, how is the price? Is it nearer 5 or 7 now........I'll wait ?

[smcl] 02/5/2018 17:26

Dave- agree totally clueless STUG/STUCK

[davevt] 02/5/2018 17:09

Stig still comparing a company that models dosage to companies that actually model drug design. That's like comparing a company that uses a computer to work out how much paint to mix to make a certain colour, vs a company that uses a computer to design the type of paint in the first place. Clueless.

[smcl] 02/5/2018 16:49

STUG/STUCK clueless!

[the stigologist] 02/5/2018 15:16

#PYC Physiomics 📈

Market is clueless. Hybridan clueless. I wonder whether anyone at PYC (prior to Dr Jim Millen joining) had a clue about the tech they were sitting on? For those unaware Dr Millen used to work in the Centre of Excellence for External Drug Discovery at GSK

[willie33] 02/5/2018 15:12

Looks like the green-eyed monster rearing it's head.

[the stigologist] 02/5/2018 15:12

Here are the valuation comparitors for PYC (Mkt Cap £4m)

In BioSimulation / Modelling & Simulation / In-Silico Clinical Trials

Certara $850m
Simulations Plus $300m

In AI/Personalised Precision Medicine

DeepMind (acquired for $500m by Google)
GRAIL inc (startup funding of $1000m+ from Bill Gates, Jeff Bezos, Big Pharma)